Skip to content
Governance Register

← US public companies

Tela Bio, Inc.

SEC CIK 1561921 · TELA · last insider filing 2026-06-11

Directors (from insider filings)

NameCapacity as filedFilings
Thomas Paul Director filed 2026 - 2026
Nohra GUY P Director filed 2026 - 2026
Neels Guido J Director filed 2026 - 2026
Capper Joseph H Director filed 2026 - 2026
Plovanic William J. Director filed 2025 - 2026
Rocchio Betty Jo Director filed 2025 - 2026
Koblish Antony Director · Chief Executive Officer filed 2019 - 2026
Blizard Jeffrey Director · President filed 2024 - 2026
O'Brien Federica F. Director filed 2019 - 2025
Colleran Lisa N Director filed 2020 - 2025
Evans Douglas G Director filed 2020 - 2025
Burgess Vincent J Director filed 2019 - 2025
Azarbarzin Kurt Director filed 2019 - 2025
Nosenzo John Director filed 2021 - 2023
Oliva Adele C Director filed 2019 - 2020
Pacira Biosciences, Inc. Director filed 2019 - 2019
Friedman Ashley Director filed 2019 - 2019
Zuga Matt Director filed 2019 - 2019
Ellis Ronald J. Jr. Director filed 2019 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Langstein Howard N. Chief Medical Officer filed 2026 - 2026
Cuca Roberto COO and CFO filed 2021 - 2026
Talmo Paul Chief Technology Officer filed 2022 - 2026
Smeykal Megan Chief Accounting Officer filed 2022 - 2026
Firestone Gregory A. Chief Commercial Officer filed 2023 - 2026
Murphy Peter C. Chief Commercial Officer filed 2020 - 2024
Greenhalgh Ellis Skott Chief Technology Officer filed 2019 - 2022
Brennan Nora Chief Financial Officer filed 2019 - 2021
Persenaire Maarten Chief Medical Officer filed 2019 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.